009420.KS
Hanall Biopharma Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 53,900.00
−2.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 1030.13x
- P/E 2028E
- 518.24x
- P/S forward
- 25.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 17.42x
- Price / sales
- 17.31x
- Price / cash flow
- -2266.22x
Enterprise value
- Enterprise value
- KRW 2.83T
- EV / sales
- 17.40x
- EV / EBITDA
- -209.06x
- EV / EBIT
- 721.36x
- Market cap
- KRW 2.82T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026